The Home Infusion Therapy Service Market is experiencing steady growth as healthcare systems increasingly shift toward patient-centered and home-based treatment models. According to WiseGuyReports, the market was valued at approximately USD 15 billion in 2025 and is projected to reach USD 25 billion by 2035, registering a CAGR of 5.3% during 2026–2035. The rising prevalence of chronic diseases, aging populations, demand for cost-effective healthcare, and growing patient preference for receiving treatment at home are key factors supporting market expansion.

Technological advancements are further transforming home infusion therapy services. Wearable infusion devices, smart infusion pumps, telehealth platforms, remote patient monitoring, and digital medication-management solutions are improving treatment monitoring, drug-delivery accuracy, and patient convenience. The market includes antibiotic therapy, pain management, chemotherapy, hormone therapy, and nutrition therapy, while important components include IV catheters, infusion pumps, IV solutions, and administration sets.

North America currently represents the leading regional market, supported by high healthcare expenditure, established home healthcare infrastructure, and increasing adoption of home-based therapies. Europe is also experiencing steady expansion, while Asia-Pacific is expected to witness robust growth as healthcare access improves, investments increase, and awareness of home care solutions rises. South America and the Middle East and Africa are also expected to grow as healthcare systems develop and adoption of home infusion services increases.

The competitive landscape includes Fresenius Kabi, Baxter International, Mediware, Hospira, B. Braun Melsungen, Zynx Health, Option Care Health, KabaFusion, CVS Health, McKesson Corporation, Cardinal Health, Medline Industries, and Smiths Medical. Recent developments include expansion of home infusion service capabilities, strategic partnerships, and the introduction of portable infusion technologies. Going forward, remote monitoring, artificial intelligence, next-generation infusion devices, patient education, and personalized care programs are expected to create additional opportunities as healthcare providers seek efficient solutions that improve patient outcomes while reducing dependence on hospital-based treatment.